 Eric Simoes
Concepts (478)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus Infections | 40 | 2018 | 139 | 5.170 |
Why?
| | Respiratory Syncytial Viruses | 18 | 2017 | 58 | 1.650 |
Why?
| | Respiratory Syncytial Virus, Human | 12 | 2018 | 81 | 1.180 |
Why?
| | Antibodies, Viral | 17 | 2025 | 674 | 0.970 |
Why?
| | Hospitalization | 19 | 2021 | 2460 | 0.830 |
Why?
| | Influenza, Human | 4 | 2024 | 624 | 0.800 |
Why?
| | Antibodies, Monoclonal | 9 | 2007 | 1505 | 0.750 |
Why?
| | Emergency Responders | 1 | 2022 | 37 | 0.720 |
Why?
| | Immunoglobulins, Intravenous | 9 | 2002 | 133 | 0.710 |
Why?
| | Macaca radiata | 8 | 2003 | 15 | 0.690 |
Why?
| | Respiratory Tract Infections | 11 | 2017 | 396 | 0.670 |
Why?
| | Otoscopes | 1 | 2021 | 4 | 0.670 |
Why?
| | Infant | 59 | 2024 | 10077 | 0.640 |
Why?
| | Pneumococcal Vaccines | 2 | 2021 | 129 | 0.630 |
Why?
| | Seasons | 9 | 2021 | 538 | 0.600 |
Why?
| | Bronchiolitis, Viral | 4 | 2013 | 10 | 0.570 |
Why?
| | Antiviral Agents | 5 | 2007 | 769 | 0.560 |
Why?
| | Respiratory Syncytial Virus Vaccines | 4 | 2013 | 39 | 0.550 |
Why?
| | Infant, Premature | 10 | 2007 | 619 | 0.460 |
Why?
| | Suicide | 1 | 2023 | 728 | 0.460 |
Why?
| | Poliovirus | 5 | 2001 | 73 | 0.450 |
Why?
| | Child, Preschool | 43 | 2024 | 11853 | 0.440 |
Why?
| | India | 12 | 2024 | 213 | 0.440 |
Why?
| | Infant, Newborn | 34 | 2025 | 6447 | 0.430 |
Why?
| | Developing Countries | 11 | 2024 | 316 | 0.420 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2025 | 440 | 0.410 |
Why?
| | Measles | 2 | 2025 | 46 | 0.380 |
Why?
| | Infant, Premature, Diseases | 4 | 2002 | 113 | 0.370 |
Why?
| | Palivizumab | 8 | 2007 | 11 | 0.370 |
Why?
| | Pneumonia | 10 | 2011 | 636 | 0.370 |
Why?
| | Immunoglobulin G | 4 | 2025 | 892 | 0.350 |
Why?
| | Population Surveillance | 4 | 2024 | 484 | 0.350 |
Why?
| | Incidence | 10 | 2024 | 2923 | 0.350 |
Why?
| | Humans | 98 | 2025 | 145474 | 0.340 |
Why?
| | Immunoglobulins | 3 | 2002 | 162 | 0.340 |
Why?
| | Viral Vaccines | 4 | 2005 | 107 | 0.330 |
Why?
| | Respiratory Sounds | 4 | 2013 | 103 | 0.320 |
Why?
| | Prospective Studies | 17 | 2024 | 8057 | 0.310 |
Why?
| | Bronchiolitis | 6 | 1999 | 87 | 0.310 |
Why?
| | Virus Diseases | 3 | 2015 | 216 | 0.300 |
Why?
| | Pneumococcal Infections | 2 | 2008 | 103 | 0.290 |
Why?
| | Child | 26 | 2024 | 22707 | 0.290 |
Why?
| | Immunization, Passive | 4 | 2002 | 90 | 0.270 |
Why?
| | Disease Outbreaks | 4 | 2021 | 419 | 0.270 |
Why?
| | Streptococcal Infections | 2 | 2024 | 171 | 0.270 |
Why?
| | Carotid Artery Thrombosis | 1 | 2007 | 6 | 0.260 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2007 | 8 | 0.260 |
Why?
| | Mucormycosis | 1 | 2007 | 18 | 0.260 |
Why?
| | Philippines | 7 | 2021 | 51 | 0.260 |
Why?
| | Paranasal Sinus Diseases | 1 | 2007 | 15 | 0.260 |
Why?
| | Carotid Artery, Internal | 1 | 2007 | 45 | 0.250 |
Why?
| | Heart Defects, Congenital | 6 | 2005 | 910 | 0.250 |
Why?
| | Spinal Cord | 2 | 2001 | 382 | 0.250 |
Why?
| | Orbital Diseases | 1 | 2007 | 37 | 0.250 |
Why?
| | Poliovirus Vaccine, Inactivated | 4 | 1988 | 27 | 0.240 |
Why?
| | Asthma | 4 | 2002 | 1797 | 0.240 |
Why?
| | Antibodies, Monoclonal, Humanized | 9 | 2007 | 992 | 0.240 |
Why?
| | Antifungal Agents | 1 | 2007 | 151 | 0.240 |
Why?
| | Female | 45 | 2025 | 78844 | 0.240 |
Why?
| | Autopsy | 2 | 2023 | 94 | 0.240 |
Why?
| | Vaccines, Attenuated | 4 | 2001 | 129 | 0.230 |
Why?
| | Infectious Disease Transmission, Vertical | 2 | 2025 | 194 | 0.230 |
Why?
| | Indonesia | 2 | 2024 | 22 | 0.230 |
Why?
| | Triazoles | 1 | 2007 | 187 | 0.230 |
Why?
| | Hepatitis B Surface Antigens | 1 | 2025 | 17 | 0.230 |
Why?
| | Sex Work | 3 | 1993 | 23 | 0.220 |
Why?
| | Pneumonia, Viral | 5 | 2000 | 389 | 0.220 |
Why?
| | Child, Hospitalized | 1 | 2005 | 54 | 0.210 |
Why?
| | Bronchopulmonary Dysplasia | 6 | 1998 | 411 | 0.210 |
Why?
| | Hepatitis B | 1 | 2025 | 66 | 0.210 |
Why?
| | Male | 39 | 2025 | 72842 | 0.210 |
Why?
| | Community-Acquired Infections | 3 | 2015 | 177 | 0.200 |
Why?
| | Child Health Services | 2 | 2003 | 186 | 0.200 |
Why?
| | Metapneumovirus | 2 | 2013 | 15 | 0.190 |
Why?
| | Leukotriene Antagonists | 1 | 2003 | 24 | 0.190 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2024 | 159 | 0.190 |
Why?
| | Fetal Blood | 1 | 2025 | 327 | 0.190 |
Why?
| | Streptococcus agalactiae | 1 | 2024 | 110 | 0.190 |
Why?
| | Measles Vaccine | 3 | 2025 | 19 | 0.190 |
Why?
| | Acetates | 1 | 2003 | 78 | 0.190 |
Why?
| | Severity of Illness Index | 7 | 2008 | 2930 | 0.180 |
Why?
| | Bronchial Provocation Tests | 1 | 2002 | 47 | 0.180 |
Why?
| | Poliomyelitis | 2 | 2001 | 35 | 0.180 |
Why?
| | Longitudinal Studies | 5 | 2023 | 2953 | 0.180 |
Why?
| | Developed Countries | 1 | 2002 | 38 | 0.180 |
Why?
| | Young Adult | 6 | 2025 | 14218 | 0.180 |
Why?
| | Adult | 18 | 2025 | 40777 | 0.180 |
Why?
| | Adolescent | 11 | 2025 | 22529 | 0.170 |
Why?
| | Quinolines | 1 | 2003 | 190 | 0.170 |
Why?
| | Altitude | 1 | 2006 | 463 | 0.170 |
Why?
| | Risk Factors | 18 | 2017 | 10885 | 0.170 |
Why?
| | Poliovirus Vaccine, Oral | 1 | 2001 | 25 | 0.170 |
Why?
| | Otoscopy | 1 | 2021 | 8 | 0.170 |
Why?
| | Immunoglobulin A | 1 | 2022 | 214 | 0.170 |
Why?
| | Cross Infection | 2 | 2013 | 260 | 0.170 |
Why?
| | Cause of Death | 1 | 2023 | 470 | 0.170 |
Why?
| | Peripheral Nerves | 1 | 2001 | 72 | 0.160 |
Why?
| | Disease Models, Animal | 5 | 2003 | 4560 | 0.160 |
Why?
| | Mothers | 2 | 2005 | 765 | 0.160 |
Why?
| | Length of Stay | 4 | 2005 | 1349 | 0.160 |
Why?
| | Africa South of the Sahara | 3 | 2025 | 54 | 0.160 |
Why?
| | Hospital Charges | 1 | 2000 | 46 | 0.160 |
Why?
| | Denmark | 3 | 2009 | 51 | 0.160 |
Why?
| | Diphtheria Toxoid | 3 | 1988 | 13 | 0.150 |
Why?
| | Pertussis Vaccine | 3 | 1988 | 24 | 0.150 |
Why?
| | Tetanus Toxoid | 3 | 1988 | 34 | 0.150 |
Why?
| | Environmental Exposure | 1 | 2003 | 578 | 0.140 |
Why?
| | Parvovirus B19, Human | 1 | 2018 | 3 | 0.140 |
Why?
| | Parvoviridae Infections | 1 | 2018 | 12 | 0.140 |
Why?
| | HN Protein | 1 | 1998 | 5 | 0.140 |
Why?
| | Colorado | 4 | 2021 | 4553 | 0.140 |
Why?
| | Respiratory Tract Diseases | 1 | 1999 | 175 | 0.140 |
Why?
| | Vaccination | 3 | 2022 | 1426 | 0.130 |
Why?
| | Cost of Illness | 1 | 2000 | 324 | 0.130 |
Why?
| | Virus Replication | 4 | 2003 | 521 | 0.130 |
Why?
| | Anxiety | 1 | 2005 | 1118 | 0.130 |
Why?
| | Rickets | 1 | 1997 | 8 | 0.130 |
Why?
| | Viral Proteins | 2 | 1998 | 350 | 0.130 |
Why?
| | Air | 1 | 1997 | 44 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2003 | 867 | 0.130 |
Why?
| | Ventilator Weaning | 1 | 1997 | 40 | 0.120 |
Why?
| | Lung Diseases | 1 | 2003 | 780 | 0.120 |
Why?
| | Stress, Psychological | 1 | 2005 | 1146 | 0.120 |
Why?
| | Education, Nursing, Continuing | 1 | 1997 | 47 | 0.120 |
Why?
| | RNA, Viral | 3 | 2001 | 692 | 0.120 |
Why?
| | Caregivers | 1 | 2005 | 1073 | 0.120 |
Why?
| | Pregnancy | 6 | 2025 | 7202 | 0.120 |
Why?
| | Acquired Immunodeficiency Syndrome | 2 | 1987 | 237 | 0.110 |
Why?
| | Neutralization Tests | 3 | 2001 | 76 | 0.110 |
Why?
| | Pharyngeal Diseases | 1 | 1995 | 17 | 0.110 |
Why?
| | In Situ Hybridization | 3 | 2001 | 318 | 0.110 |
Why?
| | Postpartum Period | 1 | 2018 | 373 | 0.110 |
Why?
| | Asia | 2 | 2025 | 70 | 0.110 |
Why?
| | Jugular Veins | 1 | 1995 | 42 | 0.110 |
Why?
| | Mouth | 1 | 1995 | 86 | 0.110 |
Why?
| | Haemophilus Infections | 1 | 1995 | 45 | 0.110 |
Why?
| | Abscess | 1 | 1995 | 77 | 0.100 |
Why?
| | Cerebral Aqueduct | 1 | 1994 | 4 | 0.100 |
Why?
| | Infectious Mononucleosis | 1 | 1994 | 10 | 0.100 |
Why?
| | Respirovirus Infections | 2 | 1993 | 14 | 0.100 |
Why?
| | Double-Blind Method | 8 | 2007 | 2062 | 0.100 |
Why?
| | Otitis Media | 1 | 1996 | 182 | 0.100 |
Why?
| | Gestational Age | 3 | 2005 | 987 | 0.100 |
Why?
| | Human bocavirus | 1 | 2013 | 1 | 0.100 |
Why?
| | Nucleoproteins | 1 | 2013 | 38 | 0.100 |
Why?
| | Triplets | 1 | 1993 | 3 | 0.100 |
Why?
| | HIV Antibodies | 1 | 1993 | 61 | 0.100 |
Why?
| | Models, Statistical | 1 | 2017 | 671 | 0.090 |
Why?
| | Hydrocephalus | 1 | 1994 | 111 | 0.090 |
Why?
| | Oropharynx | 1 | 2013 | 46 | 0.090 |
Why?
| | Prevalence | 3 | 2025 | 2865 | 0.090 |
Why?
| | Primary Health Care | 1 | 2003 | 1735 | 0.090 |
Why?
| | South Africa | 3 | 2024 | 266 | 0.090 |
Why?
| | Pediatric Nursing | 1 | 1992 | 44 | 0.090 |
Why?
| | HIV Infections | 3 | 2018 | 3193 | 0.090 |
Why?
| | Disease Management | 1 | 1997 | 653 | 0.090 |
Why?
| | Diseases in Twins | 1 | 1993 | 116 | 0.090 |
Why?
| | Vaccines, Inactivated | 2 | 2003 | 70 | 0.090 |
Why?
| | Encephalitis | 1 | 1994 | 142 | 0.090 |
Why?
| | Cohort Studies | 4 | 2018 | 6013 | 0.090 |
Why?
| | Case-Control Studies | 5 | 2018 | 3623 | 0.090 |
Why?
| | Respiratory Physiological Phenomena | 1 | 1991 | 35 | 0.090 |
Why?
| | Respiratory Function Tests | 3 | 2002 | 544 | 0.090 |
Why?
| | Community Health Workers | 1 | 1992 | 88 | 0.090 |
Why?
| | Pneumonia, Bacterial | 2 | 2009 | 113 | 0.090 |
Why?
| | Europe | 2 | 2003 | 418 | 0.090 |
Why?
| | Ulnar Nerve | 2 | 2001 | 17 | 0.080 |
Why?
| | Age Distribution | 4 | 2007 | 403 | 0.080 |
Why?
| | Genes, Viral | 1 | 1991 | 88 | 0.080 |
Why?
| | Breast Feeding | 2 | 2003 | 446 | 0.080 |
Why?
| | Thrombosis | 1 | 1995 | 400 | 0.080 |
Why?
| | Aged | 6 | 2024 | 26153 | 0.080 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 777 | 0.080 |
Why?
| | Socioeconomic Factors | 2 | 2006 | 1323 | 0.080 |
Why?
| | Time Factors | 7 | 2018 | 7123 | 0.080 |
Why?
| | DNA, Viral | 2 | 2025 | 356 | 0.080 |
Why?
| | Retrospective Studies | 6 | 2023 | 17291 | 0.080 |
Why?
| | Middle Aged | 6 | 2024 | 36215 | 0.070 |
Why?
| | Measles virus | 2 | 2025 | 21 | 0.070 |
Why?
| | Logistic Models | 4 | 2009 | 2134 | 0.070 |
Why?
| | Lung | 2 | 2001 | 4106 | 0.070 |
Why?
| | Sensitivity and Specificity | 5 | 2007 | 1997 | 0.070 |
Why?
| | Algorithms | 3 | 2009 | 1845 | 0.070 |
Why?
| | Clinical Competence | 1 | 1997 | 1243 | 0.070 |
Why?
| | Single-Blind Method | 3 | 1998 | 318 | 0.070 |
Why?
| | Mozambique | 2 | 2024 | 7 | 0.070 |
Why?
| | Protein Biosynthesis | 1 | 1991 | 452 | 0.070 |
Why?
| | Maternal-Fetal Exchange | 1 | 2009 | 170 | 0.070 |
Why?
| | Animals | 10 | 2004 | 38030 | 0.070 |
Why?
| | Respiration | 3 | 1997 | 206 | 0.070 |
Why?
| | Mucor | 1 | 2007 | 6 | 0.070 |
Why?
| | Global Health | 2 | 2017 | 403 | 0.060 |
Why?
| | Ethiopia | 2 | 1997 | 44 | 0.060 |
Why?
| | HIV-1 | 1 | 1993 | 908 | 0.060 |
Why?
| | United States | 7 | 2007 | 16098 | 0.060 |
Why?
| | Debridement | 1 | 2007 | 85 | 0.060 |
Why?
| | Meningitis, Bacterial | 1 | 2007 | 46 | 0.060 |
Why?
| | Central Nervous System Bacterial Infections | 1 | 2006 | 5 | 0.060 |
Why?
| | Reference Values | 2 | 2007 | 798 | 0.060 |
Why?
| | Weather | 1 | 2007 | 43 | 0.060 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2007 | 49 | 0.060 |
Why?
| | Probability | 1 | 2007 | 307 | 0.060 |
Why?
| | Cell Line | 3 | 2004 | 2823 | 0.060 |
Why?
| | Rectum | 2 | 2024 | 182 | 0.060 |
Why?
| | Deltaretrovirus | 1 | 1985 | 12 | 0.060 |
Why?
| | Secondary Prevention | 1 | 2007 | 251 | 0.060 |
Why?
| | Predictive Value of Tests | 5 | 2009 | 2121 | 0.060 |
Why?
| | Hepatitis B e Antigens | 1 | 2025 | 3 | 0.060 |
Why?
| | DNA, Bacterial | 1 | 2007 | 320 | 0.060 |
Why?
| | Convalescence | 1 | 2005 | 19 | 0.060 |
Why?
| | Asia, Southeastern | 1 | 2025 | 12 | 0.060 |
Why?
| | Hepatitis B virus | 1 | 2025 | 33 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 782 | 0.060 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2025 | 19 | 0.060 |
Why?
| | Athetosis | 1 | 2005 | 7 | 0.050 |
Why?
| | Chorea | 1 | 2005 | 13 | 0.050 |
Why?
| | Cyanosis | 2 | 2009 | 18 | 0.050 |
Why?
| | Antibodies, Bacterial | 2 | 2000 | 147 | 0.050 |
Why?
| | Biomedical Research | 1 | 2011 | 717 | 0.050 |
Why?
| | Bhutan | 1 | 2024 | 3 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 749 | 0.050 |
Why?
| | Fruit | 2 | 1996 | 146 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2025 | 171 | 0.050 |
Why?
| | Pediatrics | 3 | 2001 | 1121 | 0.050 |
Why?
| | Paramyxoviridae | 1 | 2004 | 2 | 0.050 |
Why?
| | Vegetables | 2 | 1996 | 161 | 0.050 |
Why?
| | Paramyxoviridae Infections | 1 | 2004 | 12 | 0.050 |
Why?
| | Family Health | 1 | 2005 | 191 | 0.050 |
Why?
| | Africa | 1 | 2024 | 119 | 0.050 |
Why?
| | Maxillary Sinusitis | 1 | 2004 | 6 | 0.050 |
Why?
| | Maxillary Sinus | 1 | 2004 | 11 | 0.050 |
Why?
| | Blood Donors | 1 | 1985 | 144 | 0.050 |
Why?
| | Sinusitis | 2 | 1999 | 227 | 0.050 |
Why?
| | Orthomyxoviridae | 1 | 2004 | 40 | 0.050 |
Why?
| | Hypothermia, Induced | 1 | 2005 | 95 | 0.050 |
Why?
| | Equipment and Supplies | 1 | 2003 | 36 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2007 | 1547 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2005 | 368 | 0.050 |
Why?
| | Orthomyxoviridae Infections | 1 | 2004 | 71 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2005 | 344 | 0.050 |
Why?
| | U937 Cells | 1 | 2003 | 28 | 0.050 |
Why?
| | Nasal Mucosa | 1 | 2004 | 112 | 0.050 |
Why?
| | Spain | 1 | 2003 | 50 | 0.050 |
Why?
| | Acute Disease | 3 | 2013 | 1036 | 0.050 |
Why?
| | Steroids | 2 | 2001 | 160 | 0.050 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 3 | 1988 | 28 | 0.050 |
Why?
| | Cell Count | 2 | 2004 | 319 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 2028 | 0.050 |
Why?
| | Viral Load | 1 | 2025 | 526 | 0.050 |
Why?
| | Cyclopropanes | 1 | 2003 | 84 | 0.050 |
Why?
| | Demography | 1 | 2003 | 282 | 0.050 |
Why?
| | Odds Ratio | 2 | 1997 | 1082 | 0.050 |
Why?
| | Climate | 1 | 2003 | 77 | 0.050 |
Why?
| | Malnutrition | 1 | 2003 | 86 | 0.050 |
Why?
| | Geography | 1 | 2003 | 187 | 0.050 |
Why?
| | Blood Transfusion | 1 | 1985 | 409 | 0.050 |
Why?
| | Vagina | 1 | 2024 | 203 | 0.040 |
Why?
| | Sulfides | 1 | 2003 | 92 | 0.040 |
Why?
| | Rhinitis | 1 | 2004 | 169 | 0.040 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2002 | 132 | 0.040 |
Why?
| | Phylogeny | 2 | 2018 | 917 | 0.040 |
Why?
| | Japan | 1 | 2002 | 149 | 0.040 |
Why?
| | Morbidity | 1 | 2003 | 322 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2002 | 137 | 0.040 |
Why?
| | Body Weight | 1 | 1986 | 971 | 0.040 |
Why?
| | Intensive Care Units, Neonatal | 2 | 1997 | 291 | 0.040 |
Why?
| | Administration, Inhalation | 2 | 2001 | 571 | 0.040 |
Why?
| | Vaccines, Subunit | 1 | 2001 | 53 | 0.040 |
Why?
| | Drug Combinations | 3 | 1988 | 396 | 0.040 |
Why?
| | Formaldehyde | 1 | 2001 | 65 | 0.040 |
Why?
| | Hospitals, District | 1 | 2001 | 7 | 0.040 |
Why?
| | Virus Shedding | 1 | 2001 | 49 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2007 | 5423 | 0.040 |
Why?
| | Bacteria | 1 | 2007 | 765 | 0.040 |
Why?
| | Treatment Outcome | 7 | 2007 | 11772 | 0.040 |
Why?
| | Health Services Research | 1 | 2003 | 391 | 0.040 |
Why?
| | Models, Immunological | 1 | 2001 | 99 | 0.040 |
Why?
| | Canada | 1 | 2002 | 431 | 0.040 |
Why?
| | Serum Albumin | 1 | 2001 | 147 | 0.040 |
Why?
| | Nerve Fibers, Myelinated | 1 | 1980 | 47 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 848 | 0.040 |
Why?
| | Hospitals, Teaching | 1 | 2001 | 120 | 0.040 |
Why?
| | Macaca | 1 | 1980 | 66 | 0.040 |
Why?
| | Tobacco Smoke Pollution | 1 | 2003 | 227 | 0.040 |
Why?
| | Poverty | 1 | 2024 | 526 | 0.040 |
Why?
| | Influenza B virus | 2 | 2004 | 47 | 0.040 |
Why?
| | Viremia | 1 | 2001 | 160 | 0.040 |
Why?
| | Mortality | 1 | 2003 | 378 | 0.040 |
Why?
| | Nasopharynx | 2 | 1998 | 72 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1852 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 2 | 2001 | 477 | 0.040 |
Why?
| | Neuroglia | 1 | 2001 | 173 | 0.040 |
Why?
| | Oxygen | 1 | 2005 | 978 | 0.040 |
Why?
| | Wrist | 1 | 1980 | 60 | 0.040 |
Why?
| | BCG Vaccine | 1 | 1999 | 27 | 0.040 |
Why?
| | Sex Factors | 2 | 2003 | 2105 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 1999 | 197 | 0.040 |
Why?
| | Influenza A virus | 2 | 2004 | 119 | 0.040 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2000 | 130 | 0.040 |
Why?
| | Intensive Care Units, Pediatric | 2 | 1998 | 288 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5904 | 0.040 |
Why?
| | Hand | 1 | 1980 | 157 | 0.040 |
Why?
| | Age Factors | 4 | 2006 | 3342 | 0.040 |
Why?
| | Fever | 2 | 2018 | 319 | 0.040 |
Why?
| | Antigens, Viral | 1 | 1999 | 182 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 2005 | 610 | 0.030 |
Why?
| | Patient Discharge | 1 | 2005 | 992 | 0.030 |
Why?
| | Parvovirus | 1 | 2018 | 13 | 0.030 |
Why?
| | Hospital Mortality | 2 | 2017 | 1038 | 0.030 |
Why?
| | Research | 1 | 2001 | 430 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 1998 | 365 | 0.030 |
Why?
| | Vaccines, Combined | 2 | 1988 | 49 | 0.030 |
Why?
| | Risk Assessment | 1 | 2007 | 3747 | 0.030 |
Why?
| | Nutrition Disorders | 1 | 1997 | 20 | 0.030 |
Why?
| | World Health Organization | 2 | 2008 | 104 | 0.030 |
Why?
| | Viral Envelope Proteins | 1 | 1998 | 98 | 0.030 |
Why?
| | Bacterial Infections | 2 | 2007 | 246 | 0.030 |
Why?
| | Child Nutrition Disorders | 1 | 1997 | 20 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2009 | 1581 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2000 | 639 | 0.030 |
Why?
| | Nursing Assessment | 1 | 1997 | 53 | 0.030 |
Why?
| | Birth Weight | 2 | 1993 | 514 | 0.030 |
Why?
| | Neutrophils | 1 | 2002 | 1124 | 0.030 |
Why?
| | Animals, Newborn | 1 | 1999 | 891 | 0.030 |
Why?
| | Dehydration | 1 | 1997 | 58 | 0.030 |
Why?
| | Pulmonary Alveoli | 1 | 1999 | 385 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1999 | 638 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2003 | 924 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 1997 | 106 | 0.030 |
Why?
| | Macrophages, Alveolar | 1 | 1999 | 373 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2001 | 692 | 0.030 |
Why?
| | Bangladesh | 1 | 2015 | 63 | 0.030 |
Why?
| | Comorbidity | 1 | 2000 | 1661 | 0.030 |
Why?
| | Lung Abscess | 1 | 1995 | 6 | 0.030 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 88 | 0.030 |
Why?
| | Blood | 1 | 2015 | 107 | 0.030 |
Why?
| | Epidemiological Monitoring | 1 | 2015 | 69 | 0.030 |
Why?
| | Nasal Cavity | 1 | 2015 | 61 | 0.030 |
Why?
| | Oxygen Inhalation Therapy | 1 | 1997 | 181 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2003 | 1101 | 0.030 |
Why?
| | Nutritional Status | 1 | 1997 | 353 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2007 | 3904 | 0.030 |
Why?
| | Eating | 2 | 1999 | 387 | 0.030 |
Why?
| | Prognosis | 1 | 2003 | 4316 | 0.030 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 1994 | 44 | 0.030 |
Why?
| | Ribavirin | 1 | 1994 | 81 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 1997 | 718 | 0.030 |
Why?
| | Opportunistic Infections | 1 | 1993 | 47 | 0.020 |
Why?
| | Counseling | 1 | 1997 | 400 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 1994 | 249 | 0.020 |
Why?
| | Influenza Vaccines | 1 | 1998 | 534 | 0.020 |
Why?
| | Herpesvirus 4, Human | 1 | 1994 | 172 | 0.020 |
Why?
| | Crowding | 1 | 1993 | 37 | 0.020 |
Why?
| | Hospitals, University | 1 | 1993 | 176 | 0.020 |
Why?
| | Radiography | 3 | 2008 | 852 | 0.020 |
Why?
| | Neurons | 1 | 2001 | 1649 | 0.020 |
Why?
| | Methods | 1 | 1991 | 68 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 1997 | 713 | 0.020 |
Why?
| | Sexual Partners | 1 | 1993 | 193 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2013 | 202 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 1991 | 23 | 0.020 |
Why?
| | RNA, Messenger | 1 | 1999 | 2803 | 0.020 |
Why?
| | Psychomotor Agitation | 1 | 1991 | 69 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 977 | 0.020 |
Why?
| | Rural Population | 1 | 2015 | 659 | 0.020 |
Why?
| | Inflammation | 1 | 2001 | 2878 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1991 | 376 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1991 | 538 | 0.020 |
Why?
| | Feeding Behavior | 1 | 1996 | 690 | 0.020 |
Why?
| | Chronic Disease | 3 | 2004 | 1808 | 0.020 |
Why?
| | Rural Health | 1 | 2009 | 87 | 0.020 |
Why?
| | Typhoid-Paratyphoid Vaccines | 1 | 1989 | 5 | 0.020 |
Why?
| | HeLa Cells | 1 | 1991 | 632 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 1993 | 558 | 0.020 |
Why?
| | Sexual Behavior | 1 | 1993 | 494 | 0.020 |
Why?
| | Salmonella typhi | 1 | 1989 | 12 | 0.020 |
Why?
| | Typhoid Fever | 1 | 1989 | 12 | 0.020 |
Why?
| | Transfection | 1 | 1991 | 926 | 0.020 |
Why?
| | Genetic Variation | 1 | 2013 | 972 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 1991 | 723 | 0.020 |
Why?
| | Kinetics | 1 | 1991 | 1567 | 0.020 |
Why?
| | Meteorological Concepts | 1 | 2007 | 6 | 0.020 |
Why?
| | Base Sequence | 1 | 1991 | 2170 | 0.020 |
Why?
| | Buchnera | 1 | 2007 | 1 | 0.020 |
Why?
| | Half-Life | 2 | 1999 | 155 | 0.020 |
Why?
| | Diet | 1 | 1995 | 1277 | 0.020 |
Why?
| | Humidity | 1 | 2007 | 49 | 0.020 |
Why?
| | Hypersensitivity, Immediate | 1 | 2006 | 41 | 0.020 |
Why?
| | Bacteriological Techniques | 1 | 2007 | 66 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1991 | 2883 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2007 | 123 | 0.010 |
Why?
| | Weaning | 1 | 1986 | 51 | 0.010 |
Why?
| | Models, Molecular | 1 | 1991 | 1598 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1985 | 164 | 0.010 |
Why?
| | Antibody Formation | 1 | 1987 | 288 | 0.010 |
Why?
| | Anti-Bacterial Agents | 3 | 2007 | 1923 | 0.010 |
Why?
| | Nigeria | 1 | 2005 | 24 | 0.010 |
Why?
| | Infant, Low Birth Weight | 1 | 1986 | 156 | 0.010 |
Why?
| | Acid-Base Equilibrium | 1 | 2005 | 23 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1300 | 0.010 |
Why?
| | Parainfluenza Virus 2, Human | 1 | 2004 | 3 | 0.010 |
Why?
| | Parainfluenza Virus 1, Human | 1 | 2004 | 3 | 0.010 |
Why?
| | Parainfluenza Virus 3, Human | 1 | 2004 | 5 | 0.010 |
Why?
| | Nasal Lavage Fluid | 1 | 2004 | 15 | 0.010 |
Why?
| | Virus Cultivation | 1 | 2004 | 31 | 0.010 |
Why?
| | Adenoviruses, Human | 1 | 2004 | 26 | 0.010 |
Why?
| | Exocrine Glands | 1 | 2004 | 5 | 0.010 |
Why?
| | Sleep | 1 | 1991 | 888 | 0.010 |
Why?
| | Immunization Schedule | 1 | 1985 | 186 | 0.010 |
Why?
| | Risk | 1 | 1987 | 919 | 0.010 |
Why?
| | Basement Membrane | 1 | 2004 | 32 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 2007 | 384 | 0.010 |
Why?
| | Immunization | 1 | 1986 | 375 | 0.010 |
Why?
| | Temperature | 1 | 2007 | 633 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1041 | 0.010 |
Why?
| | Body Temperature | 1 | 2005 | 227 | 0.010 |
Why?
| | Plasma Cells | 1 | 2004 | 79 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 1996 | 2187 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2005 | 531 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2005 | 227 | 0.010 |
Why?
| | Cardiopulmonary Bypass | 1 | 2005 | 218 | 0.010 |
Why?
| | Esophagus | 1 | 2005 | 262 | 0.010 |
Why?
| | Escherichia coli | 1 | 2007 | 835 | 0.010 |
Why?
| | Phenotype | 1 | 1991 | 3155 | 0.010 |
Why?
| | Survival Rate | 1 | 2007 | 2090 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1999 | 3922 | 0.010 |
Why?
| | Lymphocytes | 1 | 2004 | 376 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1747 | 0.010 |
Why?
| | Eosinophils | 1 | 2004 | 316 | 0.010 |
Why?
| | Metacarpophalangeal Joint | 1 | 1980 | 22 | 0.010 |
Why?
| | Biopsy | 1 | 2004 | 1082 | 0.010 |
Why?
| | Neoplasms | 1 | 1996 | 2906 | 0.010 |
Why?
| | Polysaccharides, Bacterial | 1 | 2000 | 69 | 0.010 |
Why?
| | Medical Records | 1 | 2000 | 192 | 0.010 |
Why?
| | Placebos | 1 | 1999 | 193 | 0.010 |
Why?
| | Nasal Decongestants | 1 | 1999 | 9 | 0.010 |
Why?
| | Glutamate Decarboxylase | 1 | 1999 | 165 | 0.010 |
Why?
| | Insulin Antibodies | 1 | 1999 | 103 | 0.010 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 1999 | 38 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1999 | 146 | 0.010 |
Why?
| | C-Peptide | 1 | 1999 | 190 | 0.010 |
Why?
| | Triage | 1 | 2001 | 250 | 0.010 |
Why?
| | Bacteremia | 1 | 2000 | 222 | 0.010 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 172 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 1999 | 1266 | 0.010 |
Why?
| | Physical Examination | 1 | 1997 | 243 | 0.010 |
Why?
| | Recurrence | 1 | 1999 | 1138 | 0.010 |
Why?
| | Therapeutic Equivalency | 1 | 1995 | 31 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 1999 | 740 | 0.010 |
Why?
| | Diet Surveys | 1 | 1995 | 90 | 0.010 |
Why?
| | Patient Selection | 1 | 1999 | 738 | 0.010 |
Why?
| | Nutrition Surveys | 1 | 1996 | 279 | 0.010 |
Why?
| | Random Allocation | 1 | 1995 | 365 | 0.010 |
Why?
| | Telephone | 1 | 1995 | 177 | 0.010 |
Why?
| | Marriage | 1 | 1995 | 121 | 0.010 |
Why?
| | Life Style | 1 | 1996 | 485 | 0.010 |
Why?
| | Islets of Langerhans | 1 | 1999 | 846 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1997 | 1508 | 0.010 |
Why?
| | Autoantibodies | 1 | 1999 | 1509 | 0.010 |
Why?
| | Acetaminophen | 1 | 1994 | 267 | 0.010 |
Why?
| | Pleura | 1 | 1991 | 28 | 0.010 |
Why?
| | Tropical Climate | 1 | 1991 | 15 | 0.010 |
Why?
| | Pharynx | 1 | 1991 | 59 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1992 | 280 | 0.000 |
Why?
| | Health Behavior | 1 | 1996 | 789 | 0.000 |
Why?
| | Blood Glucose | 1 | 1999 | 2341 | 0.000 |
Why?
| | Reproducibility of Results | 1 | 1997 | 3413 | 0.000 |
Why?
| | Smoking | 1 | 1996 | 1472 | 0.000 |
Why?
| | Monitoring, Physiologic | 1 | 1991 | 288 | 0.000 |
Why?
| | Alcohol Drinking | 1 | 1996 | 837 | 0.000 |
Why?
| | Injections, Subcutaneous | 1 | 1989 | 170 | 0.000 |
Why?
| | Insulin | 1 | 1999 | 2512 | 0.000 |
Why?
| | Emergency Service, Hospital | 1 | 2001 | 2381 | 0.000 |
Why?
| | Thorax | 1 | 1988 | 51 | 0.000 |
Why?
| | Antigens, Bacterial | 1 | 1989 | 126 | 0.000 |
Why?
| | Body Mass Index | 1 | 1996 | 2445 | 0.000 |
Why?
| | Sepsis | 1 | 1991 | 664 | 0.000 |
Why?
| | Exercise | 1 | 1996 | 2198 | 0.000 |
Why?
|
|
Simoes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|